Literature DB >> 34259627

CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels.

André B Goncalves1, Sarah K Hasselbalch1, Beinta B Joensen1, Sebastian Patzke2, Pernille Martens1, Signe K Ohlsen3, Mathieu Quinodoz4, Konstantinos Nikopoulos5, Reem Suleiman1, Magnus P Damso Jeppesen1, Catja Weiss1, Søren Tvorup Christensen1, Carlo Rivolta4, Jens S Andersen3, Pietro Farinelli1, Lotte B Pedersen1.   

Abstract

CEP78 is a centrosomal protein implicated in ciliogenesis and ciliary length control, and mutations in the CEP78 gene cause retinal cone-rod dystrophy associated with hearing loss. However, the mechanism by which CEP78 affects cilia formation is unknown. Based on a recently discovered disease-causing CEP78 p.L150S mutation, we identified the disease-relevant interactome of CEP78. We confirmed that CEP78 interacts with the EDD1-DYRK2-DDB1VPRBP E3 ubiquitin ligase complex, which is involved in CP110 ubiquitination and degradation, and identified a novel interaction between CEP78 and CEP350 that is weakened by the CEP78L150S mutation. We show that CEP350 promotes centrosomal recruitment and stability of CEP78, which in turn leads to centrosomal recruitment of EDD1. Consistently, cells lacking CEP78 display significantly increased cellular and centrosomal levels of CP110, and depletion of CP110 in CEP78-deficient cells restored ciliation frequency to normal. We propose that CEP78 functions downstream of CEP350 to promote ciliogenesis by negatively regulating CP110 levels via an EDD1-dependent mechanism.
© 2021, Goncalves et al.

Entities:  

Keywords:  cell biology; human

Year:  2021        PMID: 34259627     DOI: 10.7554/eLife.63731

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  7 in total

1.  3D-Structured Illumination Microscopy of Centrosomes in Human Cell Lines.

Authors:  Kari-Anne M Frikstad; Kay O Schink; Sania Gilani; Lotte B Pedersen; Sebastian Patzke
Journal:  Bio Protoc       Date:  2022-03-20

2.  Multiple ciliary localization signals control INPP5E ciliary targeting.

Authors:  Dario Cilleros-Rodriguez; Raquel Martin-Morales; Pablo Barbeito; Abhijit Deb Roy; Abdelhalim Loukil; Belen Sierra-Rodero; Gonzalo Herranz; Olatz Pampliega; Modesto Redrejo-Rodriguez; Sarah C Goetz; Manuel Izquierdo; Takanari Inoue; Francesc R Garcia-Gonzalo
Journal:  Elife       Date:  2022-09-05       Impact factor: 8.713

3.  Patient with multiple morphological abnormalities of sperm flagella caused by a novel ARMC2 mutation has a favorable pregnancy outcome from intracytoplasmic sperm injection.

Authors:  Jiaxiong Wang; Xiaoran Liu; Ce Zhang; Yongle Xu; Weizhuo Wang; Hong Li; Shenmin Yang; Jing Zhao
Journal:  J Assist Reprod Genet       Date:  2022-05-11       Impact factor: 3.357

4.  The retromer complex regulates C. elegans development and mammalian ciliogenesis.

Authors:  Shuwei Xie; Carter Dierlam; Ellie Smith; Ramon Duran; Allana Williams; Angelina Davis; Danita Mathew; Naava Naslavsky; Jyoti Iyer; Steve Caplan
Journal:  J Cell Sci       Date:  2022-05-17       Impact factor: 5.235

5.  LUBAC regulates ciliogenesis by promoting CP110 removal from the mother centriole.

Authors:  Xiao-Lin Shen; Jin-Feng Yuan; Xuan-He Qin; Guang-Ping Song; Huai-Bin Hu; Hai-Qing Tu; Zeng-Qing Song; Pei-Yao Li; Yu-Ling Xu; Sen Li; Xiao-Xiao Jian; Jia-Ning Li; Chun-Yu He; Xi-Ping Yu; Li-Yun Liang; Min Wu; Qiu-Ying Han; Kai Wang; Ai-Ling Li; Tao Zhou; Yu-Cheng Zhang; Na Wang; Hui-Yan Li
Journal:  J Cell Biol       Date:  2021-11-23       Impact factor: 8.077

Review 6.  Roles of dual specificity tyrosine-phosphorylation-regulated kinase 2 in nervous system development and disease.

Authors:  Gabriel Nicolás Santos-Durán; Antón Barreiro-Iglesias
Journal:  Front Neurosci       Date:  2022-09-08       Impact factor: 5.152

Review 7.  Regulation of Hedgehog Signal Transduction by Ubiquitination and Deubiquitination.

Authors:  Qing Zhang; Jin Jiang
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.